Monitoring safety of single-low dose primaquine co-administered with ALu in routine healthcare practice: addressing potential implementation challenges and policy options for effective roll out
Phase 3
Completed
- Conditions
- Malaria
- Registration Number
- PACTR202007653561223
- Lead Sponsor
- Ifakara Health Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Inclusion criteria include:
(i). All patients with uncomplicated P.falciparum malaria
(ii). Participants with 1 year and above
Exclusion Criteria
Exclusion criteria include:
(i). Pregnant women
(ii). Lactating mother with children of 6 months and below
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method